SE0102058D0 - New Salts II - Google Patents

New Salts II

Info

Publication number
SE0102058D0
SE0102058D0 SE0102058A SE0102058A SE0102058D0 SE 0102058 D0 SE0102058 D0 SE 0102058D0 SE 0102058 A SE0102058 A SE 0102058A SE 0102058 A SE0102058 A SE 0102058A SE 0102058 D0 SE0102058 D0 SE 0102058D0
Authority
SE
Sweden
Prior art keywords
new salts
salt
napsylate
salts
solvates
Prior art date
Application number
SE0102058A
Other languages
Swedish (sv)
Inventor
Lynne Taylor
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0102058A priority Critical patent/SE0102058D0/en
Publication of SE0102058D0 publication Critical patent/SE0102058D0/en
Priority to PCT/SE2002/001084 priority patent/WO2002100870A1/en

Links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Novel napsylate salts of formula I, or solvates of said salt, and stereoisomers thereof, as well as a process for the preparation thereof, pharmaceutical compositions containing the therapeutically active napsylate salt and the use of said active compounds in therapy.
SE0102058A 2001-06-08 2001-06-08 New Salts II SE0102058D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0102058A SE0102058D0 (en) 2001-06-08 2001-06-08 New Salts II
PCT/SE2002/001084 WO2002100870A1 (en) 2001-06-08 2002-06-04 New napsylate salts ii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102058A SE0102058D0 (en) 2001-06-08 2001-06-08 New Salts II

Publications (1)

Publication Number Publication Date
SE0102058D0 true SE0102058D0 (en) 2001-06-08

Family

ID=20284433

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102058A SE0102058D0 (en) 2001-06-08 2001-06-08 New Salts II

Country Status (2)

Country Link
SE (1) SE0102058D0 (en)
WO (1) WO2002100870A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7566738B2 (en) 2004-11-03 2009-07-28 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
US7494985B2 (en) 2004-11-03 2009-02-24 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
US20060160777A1 (en) * 2004-12-27 2006-07-20 Anders Lehmann New use of GABAbeta receptor agonists
WO2006071186A1 (en) * 2004-12-27 2006-07-06 Astrazeneca Ab Use of gabab receptor agonists
US7585996B2 (en) 2006-09-15 2009-09-08 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
US20120016021A1 (en) 2010-07-15 2012-01-19 Xenoport, Inc. Methods of treating fragile x syndrome, down's syndrome, autism and related disorders
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603408D0 (en) * 1996-09-18 1996-09-18 Astra Ab Medical use

Also Published As

Publication number Publication date
WO2002100870A1 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
CO5271691A1 (en) NEW COMPOUNDS
SE9904505D0 (en) Novel compounds
SE9904508D0 (en) New compounds
SE0200979D0 (en) New compounds
SE0202463D0 (en) Novel compounds
EP1248612A4 (en) Novel compounds and compositions as protease inhibitors
DE60112974D1 (en) Carbolinderivate
SE9903544D0 (en) Novel compounds
NO20052182L (en) New connections
BR0309343A (en) Compound, pharmaceutical composition, use of a compound, and method of treating or prophylaxis of human diseases or conditions.
BR0309342A (en) Compound, pharmaceutical composition, use of a compound, and method of treating or prophylaxis of human diseases or conditions.
MXPA05012247A (en) New benzimidazole derivatives.
DE60216233D1 (en) Carbolinderivate
DE60121461D1 (en) CONDENSED PYRIDOINDOL DERIVATIVES
GB0109122D0 (en) Novel compounds
PE20030061A1 (en) 1-BIARIL-1,8-NAPHTHYRIDIN-4-ONA AS PHOSPHODIESTERASE-4 INHIBITORS
SE0102055D0 (en) New Compounds
SE0102440D0 (en) New compound
MXPA04006041A (en) Pyridoquinoxaline antivirals.
SE0301320D0 (en) Positive modulators of nicotinic acetylcholine receptors
DE60112960D1 (en) CONDENSED PYRIDOINDOL DERIVATIVES
SE0102057D0 (en) New Salts I
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
MXPA04005484A (en) Method for preparing echinocandin derivatives.
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments